Halberd Corporation: Infectious Disease Specialist Will Guide Halberd's Extracorporeal Elimination of Disease Antigens in Animals and Then Humans
JACKSON CENTER, PA / ACCESSWIRE / March 16, 2022 / Halberd Corporation (OTC PINK:HALB) announces its entry into the next stage of research. To guide it, having successfully eliminated the Top 10 Target
United States Kostenloser Wertpapierhandel Williama Hartman Ravi Venkata Durvasula University Of New Mexico Research Funding
Source: finanznachrichten.de